Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000370459 | SCV000345353 | pathogenic | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001859722 | SCV002241042 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2024-03-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu285Glyfs*12) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 290732). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003463779 | SCV004213823 | likely pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2022-10-31 | flagged submission | clinical testing |